Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias
Launched by OXFORD UNIVERSITY HOSPITALS NHS TRUST · Mar 25, 2022
Trial Information
Current as of August 31, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the trial.
- • Male or female aged 18 years or above.
- • Indication for 12-lead ECG.
- Exclusion Criteria:
- • Unable to comply with instructions.
- • Tattoos in the wrists or fingers where the device will be placed.
- • Severe skin allergy to silicone (Apple Watch wrist band) or nickel allergies.
About Oxford University Hospitals Nhs Trust
Oxford University Hospitals NHS Trust is a leading healthcare provider in the UK, renowned for its commitment to clinical excellence, research, and innovation. As a prominent academic health organization, it integrates cutting-edge medical research with patient care, facilitating a wide range of clinical trials across various therapeutic areas. The Trust collaborates closely with the University of Oxford, leveraging its world-class expertise to advance medical knowledge and improve treatment options. With a focus on patient safety and ethical standards, Oxford University Hospitals NHS Trust is dedicated to contributing to the development of new therapies and enhancing health outcomes through rigorous scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Southampton, , United Kingdom
Birmingham, , United Kingdom
Oxford, Oxfordshire, United Kingdom
Patients applied
Trial Officials
Tim Betts, MD
Principal Investigator
Oxford University Hospitals NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials